我们的见解

AI and Tariffs Under Siege: How Can Taiwan's Biotech Industry Break the Impasse? (1)-Corporate culture.

AI and Tariffs Under Siege: How Can Taiwan's Biotech Industry Break the Impasse? (1)-Corporate culture.

AI and Tariffs Under Siege: How Can Taiwan's Biotech Industry Break the Impasse? (1)-Corporate culture.The global biotech market continues its growth trajectory, projected to rise from US$483 billion in 2024...

AI and Tariffs Under Siege: How Can Taiwan's Biotech Industry Break the Impasse? (1)-Corporate culture.

AI and Tariffs Under Siege: How Can Taiwan's Biotech Industry Break the Impasse? (1)-Corporate culture.The global biotech market continues its growth trajectory, projected to rise from US$483 billion in 2024...

Global Market Access Strategy for Innovative Wound Care Products

Global Market Access Strategy for Innovative Wound Care Products

Global wound care market entry demands regulatory compliance, strong clinical data, strategic partnerships, and tailored commercialization to overcome challenges and achieve sustainable growth.

Global Market Access Strategy for Innovative Wound Care Products

Global wound care market entry demands regulatory compliance, strong clinical data, strategic partnerships, and tailored commercialization to overcome challenges and achieve sustainable growth.

Accelerating Commercialization of Innovative Wound Care Technologies: A Biotech Roadmap

Accelerating Commercialization of Innovative Wound Care Technologies: A Biotech Roadmap

Biotech firms must strategically navigate regulations, partnerships, and clinical validation to rapidly commercialize advanced wound care technologies, improving patient outcomes through innovation.

Accelerating Commercialization of Innovative Wound Care Technologies: A Biotech Roadmap

Biotech firms must strategically navigate regulations, partnerships, and clinical validation to rapidly commercialize advanced wound care technologies, improving patient outcomes through innovation.

"A bustling Chinese pharmacy with shelves overflowing with colorful medications, a pharmacist in a white coat consulting with a patient, and a modern pharmaceutical factory in the background."

中国是亚洲最大的醫藥市场

中国是亚洲最大的市场，任何人都无法忽视。因此，IUSEA也支持进入中国市场，IUSEA中国咨询部特此分享以下政策供参考。

中国是亚洲最大的醫藥市场

中国是亚洲最大的市场，任何人都无法忽视。因此，IUSEA也支持进入中国市场，IUSEA中国咨询部特此分享以下政策供参考。

Exosomes contribute to anti-aging, including cellular communication, tissue repair, inflammation reduction, and oxidative stress mitigation.

外泌体有助于抗衰老，其作用机制包括促进细胞通讯、修复组织、减轻炎症和缓解氧化应激。

近年来，台湾的生物技术公司正在开发包括干细胞和外泌体相关产品在内的再生医学；但是，由于监管限制，只有化妆品获得了商业化批准

外泌体有助于抗衰老，其作用机制包括促进细胞通讯、修复组织、减轻炎症和缓解氧化应激。

近年来，台湾的生物技术公司正在开发包括干细胞和外泌体相关产品在内的再生医学；但是，由于监管限制，只有化妆品获得了商业化批准

Taiwan Biotech: Commercialization vs. Licensing – Strategic Choices for Global Market Entry

台湾生物科技：商业化与授权——进入全球市场的战略选择

台湾生技公司是否需要将产品商业化？还是只需在第二或第三阶段进行授权交易。台湾生技公司如何在全球市场将新产品商业化？按地区授权？分销商合作，设立分支机构或拥有自己的销售和营销团队，与合作伙伴共同营销。

台湾生物科技：商业化与授权——进入全球市场的战略选择

台湾生技公司是否需要将产品商业化？还是只需在第二或第三阶段进行授权交易。台湾生技公司如何在全球市场将新产品商业化？按地区授权？分销商合作，设立分支机构或拥有自己的销售和营销团队，与合作伙伴共同营销。